Trending...
- California: Governor Newsom signs new law to protect workers, require disclosures on AI-generated advertising - 139
- California: Governor Newsom signs legislation 9.14.2026 - 127
- Governor Newsom announces California-backed victory after Supreme Court blocks Trump's attack on vote-by-mail
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced that eight clinical abstracts evaluating the use of its novel technology were accepted for presentation during the virtual American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, Oct. 24-28.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
Tuesday, Oct 27:
About RefleXion Medical
More on The Californer
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
- Danny's Ice Cream Truck Is Coming Home to San Diego
- A3 Analytics Names Greg Snyder as Co-Founder and Chief Operating Officer
- California: Governor Newsom expands film and TV tax credits with new legislation, creates tax credit to support post-production jobs
- KayeDinero Writes Python. Does That Make Her an AI Artist? "C'mon Nah."
- Governor Newsom signs new laws to protect California elections from Trump interference
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
- 2686 "Simultaneous Integrated Boost of Lung Tumors in the Stereotactic Ablative Setting using BgRT Tracked Delivery"
- 2831 "Use of a Detailed Process Map for Clinical Workflow of a New Biology-guided Radiotherapy (BgRT) Machine"
- 2768 "Feasibility of Biology-Guided Radiotherapy for Pancreatic Tumors: An Assessment of Normalized Target SUV"
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
- SS 21 – "Increased 18F-FDG Metabolic Activity During Lung SBRT Predicts Risk of Disease Progression: Results from a Prospective Study of Serial Inter-Fraction PET/CTs"
Tuesday, Oct 27:
- 3:15 PM QP-19 – Physics – Motion Management "Feasibility of Biology-guided Radiotherapy (BgRT) Targeting FDG Avid Liver Metastases"
- 2:00 PM 2268 PV 06 Poster "FDG-PET Metrics in Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis"
- 2:00 PM 2258 PV 06 Poster "Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy"
About RefleXion Medical
More on The Californer
- Governor Newsom signs bill to protect California's sovereignty and guard against unauthorized military deployments
- Vydhai Launches AI Visibility Service for Dental Practices in ChatGPT, Google AI & Perplexity
- 11th Edition of Tomorrow's Filmmakers Today fellowship at 18th Annual Hola Mexico Film Festival
- California: Governor Newsom issues legislative update 9.18.26
- California: Governor Newsom announces appointments 9.18.2026
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
Filed Under: Business
0 Comments
Latest on The Californer
- xBxBio Opens EU, Asia and Latin America Regulatory Leadership Searches
- TitleChain Foundation Opens Public Commons Reference Project for Real-World Asset Transfer
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Chapter Enterprise and NuGuard AI Announce Strategic Partnership to Make Enterprise Agentic AI Both Role-Intelligent and Audit-Ready
- iSmile Orthodontics - San Ramon Trains Its Whole Team on AI, Invites Other Practices to Join
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Manuel Jesse Lopez Launches Official Amazon Influencer Storefront to Streamline Consumer Purchases
- Connect Names Zeb Hastings Head of Partnerships & Growth
- Server Memory Up 27 Percent Since March While DDR4 Falls 25 Percent: eRacks Publishes Its Tracking
- Sons of Morehouse Carry the Light: David Roach and Larry Calhoun Keep Independent Black Stories Alive from Stage to Screen
- Humphrey Jr. Returns Brings a Beloved Northern California Whale Story to a New Generation
- mQOL Announces Jessica Willoughby as Chief Operating Officer
- Wheelchair to Founder: At 70, Jonine Scott Turns a Personal Health Crisis Into Luna Select Market
- California: Governor Newsom announces appointments 9.17.2026
- California: Governor Newsom proclaims Constitution Day and Citizenship Day
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- California: Governor Newsom delivers on pledge to provide new financing options for Eaton and Palisades survivors
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
- Decode Digital Works Launches Executive Event Coverage Initiative